A utophagy is one of the main cellular degradation systems in eukaryotes, responsible for the elimination of longlived proteins and damaged organelles. Besides its well-documented role as a housekeeping mechanism, autophagy has recently caught the attention of groups working in the fields of microbiology and immunology, especially those working in innate immunity. In particular, the highly specific segregation and degradation of intracellular bacteria by the autophagic machinery was a matter of great interest. However, it was still unclear how the autophagy machinery could target intracellular bacteria with such specificity. We have recently analyzed the role of the intracellular peptidoglycan (PG) receptors Nod1 and Nod2 as a link between intracellular bacterial sensing and the induction of autophagy. Our results demonstrated that Nod2 recruits the critical autophagy protein ATG16L1 to the plasma membrane during bacterial invasion and that cells expressing mutations in these proteins-two of the most important associated with Crohn disease-autophagy is defective upon infection or stimulation with the bacterial peptidoglycan fragment MDP. Thus, our findings put together two genes previously reported as independent risk factors for the development of Crohn disease and open a venue in the study of new therapies to cure the disease.
The detection of microbes by our innate immune system is highly dependent on the recognition of structural components conserved among pathogens, called pathogen-associated molecular patterns (PAMPs), by germline-encoded patternrecognition molecules (PRMs). Among the molecules able to detect and initiate an innate immune response against microbial invaders are the toll-like receptors (TLRs), which are transmembrane proteins, and the Nod-like receptors (NLRs), intracellular surveillance proteins that signal from the cytosol upon microbial invasion. Two of the most well-studied NLR proteins are the bacterial peptidoglycan (PG) receptors Nod1 and Nod2. Once activated, these proteins recruit the adaptor protein RIP2 to activate NFκB and initiate a proinflammatory response that culminates with the elimination of the microbial invader, thus constituting a critical part of the innate immune system.
Recently, autophagy has gained center stage as a new mechanism employed by the innate immune system to help control infection by cytosolic microbes. However, the mechanisms underlying the recognition of intracellular pathogens by the autophagic machinery were still obscure. Therefore, we analyzed whether Nod1 and Nod2 could link bacterial sensing to the induction of a bacterial specific autophagic response. To this end, we stimulated GFP-LC3-expressing cells with bacterial PG fragments as specific activators of Nod proteins and observe an upregulation in the number of autophagosomes. Our in vivo experiments, in which we injected Nods ligands into the peritoneal cavity of wild-type and Nod1-or Nod2-deficient mice, corroborated our previous in vitro results by demonstrating that Nod1 and Nod2 can indeed trigger autophagy in response to PG sensing. These findings strongly suggested a role for Nod proteins in bacterial-induced autophagy that could have repercussions in the outcome of the infection. Indeed, as we were able to show in a series of proteins colocalize at the site of bacterial entry, suggesting that this is an important step in the formation of bacterial-targeted autophagosomes (Fig. 1) . Mutations in NOD2 are associated with an increased risk of developing Crohn disease, suggesting that defective bacterial recognition may have an impact upon the pathogenesis of Crohn disease. The most prevalent NOD2 mutation in patients with Crohn disease (L1007fsinsC-Nod2 fs) results in a protein that is defective in downstream signaling in response to peptidoglycan and MDP and that, unlike wild-type Nod2, fails to localize to the plasma membrane.
In our study, we show that cells expressing Nod2 fs fail not only to signal for NFκB activation, but also to recruit ATG16L1 to the bacterial entry site to initiate the this is the first observation of a Nod1-or Nod2-dependent but RIP2-independent event, as RIP2 is absolutely required for the induction of proinflammatory responses upon activation of Nod1 and Nod2.
As we continued to seek the mechanism underlying the induction of autophagy by Nod proteins, we hypothesized that, since the classic signaling pathway was not involved, Nod proteins could directly interact with components of the autophagic machinery. To test this hypothesis, we performed a series of experiments in which we co-expressed Nod proteins and different versions of the critical autophagy protein ATG16L1 and learned that both Nod1 and Nod2 are able to recruit ATG16L1 to the plasma membrane and that, during infection, these experiments, Nod1-and Nod2-deficient cells display impaired bacterial-targeted autophagy upon infection with Shigella flexneri or Listeria monocytogenes, resulting in increased intracellular bacterial burden, once again strengthening the importance of Nod proteins as initiators of infection-driven autophagy. As we searched for the mechanism involved in Nod-dependent autophagy, we unexpectedly found that the adaptor protein RIP2 was not required for such a response, as RIP2-deficient cells display normal bacterial-targeted autophagy. In addition, activation of NFκB, that is downstream of RIP2, is also dispensable for induction of autophagy, as NEMO-deficient cells also display similar levels of autophagy when compared to control cells. Interestingly, Figure 1 . upon bacterial invasion, nod2 is recruited to the entry site to (i) induce the activation of the transcription factor nFκB through the recruitment of the adaptor protein Rip2 resulting in an intense inflammatory response, and (ii) to induce an early autophagic response by recruiting the essential autophagy protein Atg16L1 (and possibly other Atg proteins) to the bacterial entry site. the most common nod2 mutation associated with crohn disease, which does not localize at the bacterial entry site, is unable to induce either response.
formation of autophagosomes around invading bacteria (Fig. 1) . Autophagy, in turn, has also been previously associated with Crohn disease. Independent genomewide association studies demonstrate that individuals homozygous for a singlenucleotide polymorphism (rs2241880) in ATG16L1 have a greater risk for developing Crohn disease. Interestingly, when cells from donors homozygous for this polymorphism are stimulated with Nod2 agonists we do not observe an upregulation in the formation of autophagosomes, in contrast to what we observed with cells from donors carrying the normal allele.
In summary, our results bring together two of the most important genes associated with Crohn disease, establishing a new axis (Nod2-ATG16L1) whose dysfunction might contribute to the development of Crohn disease. In a broader view, these findings may also have an impact upon the innate immunity and cellular microbiology fields with the possibility that Nod1 and Nod2 interact with other ATG proteins, modulating their activity and consequently autophagy.
